Abstract |
The inhibitory effect of betulinic acid (BA) on hepatic glucose production was examined in HepG2 cells and high fat diet (HFD)-fed ICR mice. BA significantly inhibited the hepatic glucose production (HGP) and gene expression levels of PGC-1α, PEPCK, and G6Pase. BA activated AMPK and suppressed the expression level of phosphorylated CREB. These effects were all abolished in the presence of compound C (an AMPK inhibitor). Moreover, inhibition of AMPK by overexpression of dominant negative AMPK prevented BA from suppression of HGP, indicating that the inhibitory effect of BA on HGP is AMPK-dependent. In addition, BA markedly phosphorylated CAMKK, and phosphorylation of AMPK and ACC, and suppression of HGP were all reversed in the presence of STO-609 (a CAMKK inhibitor), suggesting that CAMKK is an upstream kinase for AMPK. In an animal study, HFD-fed ICR mice were orally administered with 5 or 10 mg of BA per kg (B5 and B10) for three weeks. Plasma glucose, triglyceride, and the insulin resistance index of the B10 group were decreased by 34%, 59%, and 38%, respectively. In a pyruvate tolerance test, pyruvate-induced glucose excursion was decreased by 27% when mice were pretreated with 10 mg/kg of BA. In summary, BA effectively ameliorates hyperglycemia through inhibition of hepatic gluconeogenesis via modulating the CAMKK-AMPK-CREB signaling pathway.
|
Authors | Soo Jung Kim, Hai Yan Quan, Kyong Ju Jeong, Do Yeon Kim, Go woon Kim, Hee Kyung Jo, Sung Hyun Chung |
Journal | Journal of agricultural and food chemistry
(J Agric Food Chem)
Vol. 62
Issue 2
Pg. 434-42
(Jan 15 2014)
ISSN: 1520-5118 [Electronic] United States |
PMID | 24354358
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CREB1 protein, human
- Cyclic AMP Response Element-Binding Protein
- Enzyme Inhibitors
- Hypoglycemic Agents
- Pentacyclic Triterpenes
- Triterpenes
- Calcium-Calmodulin-Dependent Protein Kinase Kinase
- AMP-Activated Protein Kinases
- Glucose
- Betulinic Acid
|
Topics |
- AMP-Activated Protein Kinases
(antagonists & inhibitors, metabolism)
- Animals
- Calcium-Calmodulin-Dependent Protein Kinase Kinase
(antagonists & inhibitors, metabolism)
- Cyclic AMP Response Element-Binding Protein
(metabolism)
- Diabetes Mellitus, Type 2
(drug therapy)
- Diet, High-Fat
- Enzyme Activation
(drug effects)
- Enzyme Inhibitors
(pharmacology)
- Gene Expression
(drug effects)
- Gluconeogenesis
(drug effects, genetics)
- Glucose
(biosynthesis)
- Hep G2 Cells
- Humans
- Hyperglycemia
(drug therapy)
- Hypoglycemic Agents
(pharmacology)
- Liver
(drug effects, metabolism)
- Mice
- Mice, Inbred ICR
- Pentacyclic Triterpenes
- Phosphorylation
(drug effects)
- Signal Transduction
(drug effects)
- Triterpenes
(pharmacology)
- Betulinic Acid
|